Advanced search
Publication Cover
Lung Cancer: Targets and Therapy Volume 14, 2023 - Issue
Submit an article Journal homepage
611
Views
6
CrossRef citations to date
0
Altmetric
REVIEW

Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno

Danielle Brazel1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USAView further author information
,
Sai-Hong Ignatius Ou1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA;2 Chao Family Comprehensive Cancer Center, Orange, CA, USAORCID Iconhttps://orcid.org/0000-0002-1764-4975View further author information
ORCID Icon &
Misako Nagasaka1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA;2 Chao Family Comprehensive Cancer Center, Orange, CA, USA;3 St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5308-615XView further author information
ORCID Icon
Pages 1-9 | Received 21 Jun 2022, Accepted 22 Dec 2022, Published online: 05 Jan 2023

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yu Saida, Satoshi Watanabe & Toshiaki Kikuchi. (2023) Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects. OncoTargets and Therapy 16, pages 657-671.
Read now

Articles from other publishers (5)

Joud Hajjar, Mohamed H. Derbala & Aung Naing. (2023) Unlocking the Potential of Anti-TIGIT Therapy—Between Promise and Challenges. JAMA Oncology 9:11, pages 1503.
Crossref
Tianming Zhang, Wenjun Li, Danbei Diwu, Lijun Chen, Xi Chen & Hong Wang. (2023) Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a Bayesian network meta-analysis. Frontiers in Immunology 14.
Crossref
J. Randolph Hecht, Jasmine Mitchell, Maria Pia Morelli, Gayathri Anandappa & James C. Yang. (2023) Next-Generation Approaches to Immuno-Oncology in GI Cancers. American Society of Clinical Oncology Educational Book:43.
Crossref
Frankie Chi Fat Ko, Sheng Yan, Ka Wai Lee, Sze Kwan Lam & James Chung Man Ho. (2023) Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy. Biomolecules 13:6, pages 902.
Crossref
楠楠 于. (2023) Research Status and Prospect of Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer. Advances in Clinical Medicine 13:08, pages 12559-12570.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.